Intervention 1: Patients in the intervention group received 420 milligrams of silymarin tablets, three times per day. Intervention 2: Patients in the control group received placebo tablets, three time

2 trials

Sponsors

Vice chancellor for research, Mazandaran University of Medical Sciences, Mazandaran University of Medical Sciences

Conditions

Thalassaemia. Beta thalassaemiaThalassemia. Beta thalassaemia

Phase 3

Effect of Silymarin on Serum Ferritin and Iron Level in ß-thalassemia Patients

Active, not recruitingIRCT2015101211819N2

Vice chancellor for research, Mazandaran University of Medical SciencesThalassaemia. Beta thalassaemia

Start: 2014-12-22Target: 70Updated: 2018-02-22

Unknown Phase

Effect of Silymarin on Oxidative Stress Status in ß-thalassemia Patients

Active, not recruitingIRCT2015101411819N4

Mazandaran University of Medical SciencesThalassemia. Beta thalassaemia

Start: 2014-12-22Target: 70Updated: 2018-02-22

Related Papers

The effect of aqueous extract of Iranian oak (Quercus brantii) on lipid profile and liver enzymes in beta-thalassemia patients: a randomized controlled trial, double-blind, placebo-controlled

Frontiers in Nutrition2025-03-26

The effect of aqueous extract of Iranian oak (Quercus brantii) on antioxidant capacity and oxidative stress in beta-thalassemia patients: Randomized controlled trial.

2024-04-04